Peripheral manifestations of HD have been increasingly recognized with recent transcriptomic analyses identifying significant upregulation of PLCB4, UBE2D3, APC, and ROCK1 in fibroblasts derived from HD patients compared with controls. Here, PLCB4 is linked to Huntington disease.